Eledon Pharmaceuticals, Inc.

US$2.60As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:ELDNHealthcare
Country USA
PE (Fwd) •••
TSR 9Y CAGR (31.46%)
Div yield —
ROE (110.71%)
Biotechnology
Beta (5Y) 0.96
PE TTM —
TSR TTM (39.70%)
Mkt cap US$211.9M
ROIC (58.97%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$2.76
5.88%
(44.26%)
Hold 2|2|4|11|3
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.04
0.04
0.04
0.04
16.47%
27.41%
28.47%
21.23%
Revenue$M
11.39
11.85
12.02
12.73
15.75%
13.85%
13.07%
13.55%
Peers (US$211.9M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
1.067
(0.193)
(0.145)
EBIT/Intx
1.980
0.084
0.087
Own earn%
29.41
(112.52)
(104.57)
Sh yield%
20.50
40.65
44.96
Owners
Insiders/Inst%
14.63
45.33
Short interest%
0.72
SBC / revenue%
0.74
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
16
Op margin range%
19–28
$1 testx
0.0
Incr. ROIC%
7